XETRA - Delayed Quote EUR

SynBiotic SE (SBX.DE)

Compare
4.9300
-0.0100
(-0.20%)
At close: January 10 at 5:36:02 PM GMT+1

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Daniel Kruse Managing Director -- -- --

SynBiotic SE

Barer Strasse 7
Munich, 80333
Germany
https://www.synbiotic.com
Sector: 
Healthcare
Full Time Employees: 
55

Description

SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names. The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE. SynBiotic SE was incorporated in 2024 and is based in Munich, Germany.

Corporate Governance

SynBiotic SE’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

27N0.DE CANNOVUM CANNABIS AG I
0.5300
+0.95%
 
H6D0.DE Haleon plc
4.4650
-3.12%
 
0OG0.F Organigram Holdings Inc.
1.5260
-6.27%
 
B8FK.DE Biofrontera AG
2.2700
0.00%
 
HIGH.DE Cantourage Group SE
4.8200
0.00%
 
ZOE.DE Zoetis Inc.
160.64
+0.59%
 
BXT.DE BioNxt Solutions Inc.
0.2630
-3.66%
 
HIGH.F Cantourage Group SE
4.6200
-3.75%
 
VIA.DE Viatris Inc.
11.36
-1.65%
 
APPH.DE Apontis Pharma AG
10.20
+0.99%